RVM
Robinson Value Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Sell |
56,769
-272
| -0.5% | -$10.4K | 1.37% | 30 |
|
|
2025
Q1 | $2.21M | Sell |
57,041
-60
| -0.1% | -$2.32K | 1.43% | 32 |
|
|
2024
Q4 | $1.93M | Buy |
57,101
+1,494
| +3% | +$50.5K | 1.28% | 35 |
|
|
2024
Q3 | $2.27M | Sell |
55,607
-60,849
| -52% | -$2.49M | 1.48% | 30 |
|
|
2024
Q2 | $4.48M | Sell |
116,456
-2,414
| -2% | -$92.9K | 3.12% | 7 |
|
|
2024
Q1 | $5.1M | Sell |
118,870
-9,209
| -7% | -$395K | 3.42% | 6 |
|
|
2023
Q4 | $4.75M | Sell |
128,079
-37
| -0% | -$1.37K | 3.12% | 7 |
|
|
2023
Q3 | $4.64M | Sell |
128,116
-3,561
| -3% | -$129K | 3.46% | 5 |
|
|
2023
Q2 | $4.69M | Buy |
131,677
+2,738
| +2% | +$97.6K | 3.4% | 4 |
|
|
2023
Q1 | $4.59M | Sell |
128,939
-3,179
| -2% | -$113K | 3.52% | 4 |
|
|
2022
Q4 | $4.64M | Buy |
132,118
+1,142
| +0.9% | +$40.1K | 4% | 3 |
|
|
2022
Q3 | $3.86M | Buy |
130,976
+35,803
| +38% | +$1.05M | 3.84% | 4 |
|
|
2022
Q2 | $4.14M | Sell |
95,173
-673
| -0.7% | -$29.3K | 3.84% | 5 |
|
|
2022
Q1 | $4.18M | Sell |
95,846
-1,831
| -2% | -$79.8K | 3.24% | 7 |
|
|
2021
Q4 | $4.31M | Buy |
97,677
+687
| +0.7% | +$30.3K | 3.54% | 7 |
|
|
2021
Q3 | $3.71M | Buy |
96,990
+49,846
| +106% | +$1.9M | 3.31% | 7 |
|
|
2021
Q2 | $1.88M | Sell |
47,144
-156
| -0.3% | -$6.21K | 1.53% | 29 |
|
|
2021
Q1 | $1.69M | Sell |
47,300
-2,350
| -5% | -$83.9K | 1.39% | 31 |
|
|
2020
Q4 | $1.83M | Buy |
+49,650
| New | +$1.83M | 1.74% | 28 |
|